Analyst Activity – FBR & Co Reiterates Buy on BioDelivery Sciences International (NASDAQ:BDSI)

58

Analyst Ratings For BioDelivery Sciences International (NASDAQ:BDSI)

Story continues below

Today, FBR & Co reiterated its Buy rating on BioDelivery Sciences International (NASDAQ:BDSI) with a price target of $4.00.

There are 1 sell rating, 1 hold rating, 3 buy ratings on the stock.

The current consensus rating on BioDelivery Sciences International (NASDAQ:BDSI) is Hold (Score: 2.40) with a consensus target price of $3.80 per share, a potential 100.00% upside.

Some recent analyst ratings include

  • 3/20/2017-FBR & Co Reiterated Rating of Buy.
  • 3/20/2017-Janney Montgomery Scott Reiterated Rating of Buy.
  • 8/10/2016-Piper Jaffray Companies Reiterated Rating of Sell.
  • 9/18/2015-William Blair Reiterated Rating of Buy.

Dividend information for BioDelivery Sciences International (NASDAQ:BDSI)

.
Recent Insider Trading Activity For BioDelivery Sciences International (NASDAQ:BDSI)
BioDelivery Sciences International (NASDAQ:BDSI) has insider ownership of 9.00% and institutional ownership of 53.57%.

  • On 1/30/2017 Niraj Vasisht, Insider, sold 6,905 with an average share price of $1.91 per share and the total transaction amounting to $13,188.55. View SEC Filing
  • On 12/1/2016 Samuel P. Sears, Jr., Director, sold 12,000 with an average share price of $1.67 per share and the total transaction amounting to $20,040.00. View SEC Filing
  • On 11/23/2016 Barry I Feinberg, Director, bought 2,000 with an average share price of $1.67 per share and the total transaction amounting to $3,340.00. View SEC Filing
  • On 11/17/2016 Barry I Feinberg, Director, bought 3,000 with an average share price of $1.87 per share and the total transaction amounting to $5,610.00. View SEC Filing
  • On 9/23/2016 Francis E Odonnell Jr, Director, sold 100,000 with an average share price of $2.57 per share and the total transaction amounting to $257,000.00. View SEC Filing
  • On 9/23/2016 Niraj Vasisht, Insider, sold 47,000 with an average share price of $2.43 per share and the total transaction amounting to $114,210.00. View SEC Filing
  • On 9/22/2016 Paolantonio Ernest Robert De, CFO, sold 14,800 with an average share price of $2.44 per share and the total transaction amounting to $36,112.00. View SEC Filing

About BioDelivery Sciences International (NASDAQ:BDSI)
BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company’s products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company’s United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.

Recent Trading Activity for BioDelivery Sciences International (NASDAQ:BDSI)
Shares of BioDelivery Sciences International closed the previous trading session at 1.90 0.00 0.00% with 743,395 shares trading hands.

An ad to help with our costs